Alzheimer's disease (AD) is a public health priority for the 21st century. Risk reduction
currently revolves around lifestyle changes with much research trying to elucidate the …

Alzheimer's disease (AD) is the leading cause of dementia among the elderly population;
however, knowledge about genetic risk factors involved in disease progression is limited …

Alzheimer's disease (AD) has no cure, but early detection and risk prediction could allow
earlier intervention. Genetic risk factors may differ between ethnic populations. To discover …

Background Genome-wide association studies of Alzheimer's disease (AD) have identified a
number of significant risk loci, the majority of which lie in non-coding regions of the genome …

Importance Despite Alzheimer disease (AD) and Parkinson disease (PD) being clinically
distinct entities, there is a possibility of a pathological overlap, with some genome-wide …

While genome wide association studies (GWASs) of Alzheimer's Disease (AD) in European
(EUR) ancestry cohorts have identified approximately 83 potentially independent AD risk …

The literature on GWAS (genome-wide association studies) data suggests that very large
sample sizes (for example, 50,000 cases and 50,000 controls) may be required to detect …

Neuropsychiatric symptoms (NPS) such as depression, apathy, aggression, and psychosis
are now recognized as core features of Alzheimer's disease (AD), and there is a general …

Alzheimer's disease (AD) is a complex disorder influenced by environmental and genetic
factors. Recent work has identified 11 AD markers in 10 loci. We used Genome-wide …

Alzheimer's disease (AD) is a progressive neurodegenerative disease associated with a
complex genetic etiology. Besides the apolipoprotein E ε4 (APOE ε4) allele, a few dozen …